FibroGen, Astellas Open Wide: Oral Anemia Drug to Phase III
Wading into Phase III waters with a new class of anemia drugs, FibroGen Inc. and partner Astellas Pharma Inc. hope to show benefit with their orally given drug not only in the condition related to chronic kidney disease (CKD), but also in hypertension and elevated cholesterol.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter